GLP-1 receptor agonists work partly by activating specific neurons in the dorsomedial hypothalamus that create a feeling of fullness even before food is consumed, interacting with appetite-regulating NPY/AgRP neurons.
DMH GLP-1R neuronsSpecific hypothalamic neurons identified as encoding preingestive satiation activated by GLP-1 receptor agonists
What the researchers found
GLP-1RA administration to patients with obesity produced heightened preingestive satiation — feeling full before eating. Analysis of human and mouse brain tissue identified GLP-1 receptor neurons in the dorsomedial hypothalamus (DMH) as the key mediators.
Optogenetic activation of DMH GLP-1R neurons directly caused satiation in mice. Calcium imaging showed these neurons actively encode preingestive satiation signals. GLP-1RA administration specifically increased DMH GLP-1R neuron activity during eating behavior. The mechanism involves interplay between DMH GLP-1R neurons and NPY/AgRP neurons in the arcuate nucleus — the brain's primary hunger-promoting neurons.
Why it matters
Despite GLP-1 drugs being prescribed to millions, no one fully understood which brain circuits they activate to reduce appetite. This Science paper identifies the specific neurons and circuit — DMH GLP-1R neurons interacting with arcuate NPY/AgRP neurons — providing the first complete picture. This knowledge could lead to even more targeted obesity treatments.
How the study worked
This translational study combined human clinical observations (GLP-1RA administration to patients with obesity), human and mouse brain tissue analysis, optogenetics (light-activated neuron control), and in vivo calcium imaging in mice to identify and characterize the brain circuits mediating GLP-1RA effects on satiation.
What this study cannot tell us
The detailed circuit mapping was performed in mice, and while human brain samples and clinical observations were included, the full mechanistic validation in humans is still indirect. The study focused on preingestive satiation specifically; other mechanisms by which GLP-1RAs affect food intake (nausea, gastric emptying, reward pathways) were not the focus. Individual variation in DMH GLP-1R neuron responses was not extensively characterized.
How to read the evidence
This is a high-impact translational study published in Science combining human clinical data with rigorous mouse neuroscience (optogenetics, calcium imaging). The evidence for the identified circuit is strong, though some findings await direct human neural confirmation.
When this study was published
Published in 2024 in Science, one of the world's top scientific journals. This is a recent and highly significant discovery in understanding how GLP-1 drugs work in the brain.
The bigger picture
This is a landmark paper that moves beyond the clinical observation that 'GLP-1 drugs reduce appetite' to explain exactly how, at the level of specific neurons and circuits. Understanding this mechanism opens doors to designing next-generation obesity drugs that target these circuits more precisely, potentially with fewer side effects than current GLP-1 receptor agonists.
Questions still open
- Could drugs that specifically target DMH GLP-1R neurons achieve weight loss with fewer gastrointestinal side effects than current GLP-1 RAs?
- Do the same brain circuits explain why some patients respond better to GLP-1 drugs than others?
- How do DMH GLP-1R neurons interact with the brain's reward circuits that drive food cravings?
Common questions
What is preingestive satiation?
Could this discovery lead to better weight loss drugs?
Read the original research
GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans.
Science (New York, N.Y.), 385(6707), 438-446
Citation
Kim, Kyu Sik; Park, Joon Seok; Hwang, Eunsang; Park, Min Jung; Shin, Hwa Yun; Lee, Young Hee; Kim, Kyung Min; Gautron, Laurent; Godschall, Elizabeth; Portillo, Bryan; Grose, Kyle; Jung, Sang-Ho; Baek, So Lin; Yun, Young Hyun; Lee, Doyeon; Kim, Eunseong; Ajwani, Jason; Yoo, Seong Ho; Güler, Ali D; Williams, Kevin W; Choi, Hyung Jin. (2024). GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans.. Science (New York, N.Y.), 385(6707), 438-446. https://doi.org/10.1126/science.adj2537